Literature DB >> 26265202

Prospectively Identified Incident Testicular Cancer Risk in a Familial Testicular Cancer Cohort.

Anand Pathak1, Charleen D Adams1, Jennifer T Loud1, Kathryn Nichols2, Douglas R Stewart1, Mark H Greene3.   

Abstract

BACKGROUND: Human testicular germ cell tumors (TGCT) have a strong genetic component and a high familial relative risk. However, linkage analyses have not identified a rare, highly penetrant familial TGCT (FTGCT) susceptibility locus. Currently, multiple low-penetrance genes are hypothesized to underlie the familial multiple-case phenotype. The observation that two is the most common number of affected individuals per family presents an impediment to FTGCT gene discovery. Clinically, the prospective TGCT risk in the multiple-case family context is unknown.
METHODS: We performed a prospective analysis of TGCT incidence in a cohort of multiple-affected-person families and sporadic-bilateral-case families; 1,260 men from 140 families (10,207 person-years of follow-up) met our inclusion criteria. Age-, gender-, and calendar time-specific standardized incidence ratios (SIR) for TGCT relative to the general population were calculated using SEER*Stat.
RESULTS: Eight incident TGCTs occurred during prospective FTGCT cohort follow-up (versus 0.67 expected; SIR = 11.9; 95% CI, 5.1-23.4; excess absolute risk = 7.2/10,000). We demonstrate that the incidence rate of TGCT is greater among bloodline male relatives from multiple-case testicular cancer families than that expected in the general population, a pattern characteristic of adult-onset Mendelian cancer susceptibility disorders. Two of these incident TGCTs occurred in relatives of sporadic-bilateral cases (0.15 expected; SIR = 13.4; 95% CI, 1.6-48.6).
CONCLUSIONS: Our data are the first to indicate that despite relatively low numbers of affected individuals per family, members of both multiple-affected-person FTGCT families and sporadic-bilateral TGCT families comprise high-risk groups for incident testicular cancer. IMPACT: Men at high TGCT risk might benefit from tailored risk stratification and surveillance strategies. ©2015 American Association for Cancer Research.

Entities:  

Mesh:

Year:  2015        PMID: 26265202      PMCID: PMC4592450          DOI: 10.1158/1055-9965.EPI-14-1240

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  51 in total

1.  Fertility among brothers of patients with testicular cancer.

Authors:  Lorenzo Richiardi; Olof Akre
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2005-11       Impact factor: 4.254

2.  Familial testicular cancer and second primary cancers in testicular cancer patients by histological type.

Authors:  C Dong; I Lönnstedt; K Hemminki
Journal:  Eur J Cancer       Date:  2001-10       Impact factor: 9.162

Review 3.  Screening for testicular cancer: an evidence review for the U.S. Preventive Services Task Force.

Authors:  Kenneth Lin; Ruta Sharangpani
Journal:  Ann Intern Med       Date:  2010-09-21       Impact factor: 25.391

4.  Cancer risk in fathers and brothers of testicular cancer patients in Denmark. A population-based study.

Authors:  T Westergaard; J H Olsen; M Frisch; N Kroman; J W Nielsen; M Melbye
Journal:  Int J Cancer       Date:  1996-05-29       Impact factor: 7.396

Review 5.  The prevalence of familial testicular cancer: an analysis of two patient populations and a review of the literature.

Authors:  K P Dieckmann; U Pichlmeier
Journal:  Cancer       Date:  1997-11-15       Impact factor: 6.860

6.  Environmental, occupational and familial risks for testicular cancer: a hospital-based case-control study.

Authors:  Marie Walschaerts; Audrey Muller; Jacques Auger; Louis Bujan; Jean-François Guérin; Dominique Le Lannou; André Clavert; Alfred Spira; Pierre Jouannet; Patrick Thonneau
Journal:  Int J Androl       Date:  2007-08

7.  Familial testicular cancer and urogenital developmental anomalies.

Authors:  D J Tollerud; W A Blattner; M C Fraser; L M Brown; L Pottern; E Shapiro; A Kirkemo; T H Shawker; N Javadpour; K O'Connell
Journal:  Cancer       Date:  1985-04-15       Impact factor: 6.860

8.  Multi-stage genome-wide association study identifies new susceptibility locus for testicular germ cell tumour on chromosome 3q25.

Authors:  Kevin Litchfield; Razvan Sultana; Anthony Renwick; Darshna Dudakia; Sheila Seal; Emma Ramsay; Silvana Powell; Anna Elliott; Margaret Warren-Perry; Rosalind Eeles; Julian Peto; Zsofia Kote-Jarai; Kenneth Muir; Jeremie Nsengimana; Michael R Stratton; Douglas F Easton; D Timothy Bishop; Robert A Huddart; Nazneen Rahman; Clare Turnbull
Journal:  Hum Mol Genet       Date:  2014-10-03       Impact factor: 6.150

9.  Increased prevalence of testicular microlithiasis in men with familial testicular cancer and their relatives.

Authors:  L A Korde; A Premkumar; C Mueller; P Rosenberg; C Soho; G Bratslavsky; M H Greene
Journal:  Br J Cancer       Date:  2008-10-07       Impact factor: 7.640

10.  Meta-analysis identifies four new loci associated with testicular germ cell tumor.

Authors:  Charles C Chung; Peter A Kanetsky; Zhaoming Wang; Michelle A T Hildebrandt; Roelof Koster; Rolf I Skotheim; Christian P Kratz; Clare Turnbull; Victoria K Cortessis; Anne C Bakken; D Timothy Bishop; Michael B Cook; R Loren Erickson; Sophie D Fosså; Kevin B Jacobs; Larissa A Korde; Sigrid M Kraggerud; Ragnhild A Lothe; Jennifer T Loud; Nazneen Rahman; Eila C Skinner; Duncan C Thomas; Xifeng Wu; Meredith Yeager; Fredrick R Schumacher; Mark H Greene; Stephen M Schwartz; Katherine A McGlynn; Stephen J Chanock; Katherine L Nathanson
Journal:  Nat Genet       Date:  2013-05-12       Impact factor: 38.330

View more
  3 in total

Review 1.  The genomic landscape of testicular germ cell tumours: from susceptibility to treatment.

Authors:  Kevin Litchfield; Max Levy; Robert A Huddart; Janet Shipley; Clare Turnbull
Journal:  Nat Rev Urol       Date:  2016-06-14       Impact factor: 14.432

2.  Racial differences in testicular cancer in the United States: descriptive epidemiology.

Authors:  Yang Li; Qi Lu; Yu Wang; Shuangge Ma
Journal:  BMC Cancer       Date:  2020-04-06       Impact factor: 4.430

3.  Molecular Basis of Cisplatin Resistance in Testicular Germ Cell Tumors.

Authors:  Violeta Bakardjieva-Mihaylova; Karolina Skvarova Kramarzova; Martina Slamova; Michael Svaton; Katerina Rejlova; Marketa Zaliova; Alena Dobiasova; Karel Fiser; Jan Stuchly; Marek Grega; Blanka Rosova; Roman Zachoval; Petr Klezl; Vaclav Eis; Eva Kindlova; Tomas Buchler; Jan Trka; Ludmila Boublikova
Journal:  Cancers (Basel)       Date:  2019-09-06       Impact factor: 6.639

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.